Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2013

01-06-2013 | Article

Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation

Authors: K. Hayakawa, D. Marchaim, P. Bathina, E. T. Martin, J. M. Pogue, B. Sunkara, S. Kamatam, K. Ho, L. B. Willis, M. Ajamoughli, D. Patel, A. Khan, K. P. Lee, U. Suhrawardy, K. K. Jagadeesh, S. M. L. Reddy, M. Levine, F. Ahmed, A. M. Omotola, M. Mustapha, J. A. Moshos, M. J. Rybak, K. S. Kaye

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2013

Login to get access

Abstract

In the majority of cases of vancomycin-resistant Staphylococcus aureus (VRSA), vancomycin-resistant Enterococcus faecalis (VR E. faecalis) served as the vanA donor to S. aureus. Previous studies that evaluated the risk factors for co-colonization with VRE and MRSA did not differentiate between VR E. faecalis and VR E. faecium. This study aimed to identify variables associated with VR E. faecalis and MRSA co-colonization. A retrospective case–control study from January 2008 to December 2009 was conducted at the Detroit Medical Center. Data were extracted from charts and pharmacy records. Unique patients co-colonized with VR E. faecalis and MRSA (defined as isolation of MRSA within 7 days of VR E. faecalis isolation) were compared with patients with VR E. faecalis who were not co-colonized with MRSA. A total of 546 patients with VR E. faecalis isolation were identified. 85 (15.6 %) VR E. faecalis patients were co-colonized with MRSA and 461 (84.4 %) VR E. faecalis patients were not co-colonized with MRSA. The mean age of the study cohort was 65.9 ± 16.4 years, 424 (77.7 %) were African–American, and 270 (49.5 %) were residing in long-term care institutions. Independent predictors of co-colonization of VR E. faecalis and MRSA were male gender, impaired consciousness, ICU stay prior to VR E. faecalis isolation, indwelling devices, and isolation of VR E. faecalis from wounds. MRSA was frequently isolated from the same culture specimen as VR E. faecalis (n = 39, 45.9 %), most commonly from wounds. This large study of patients with VR E. faecalis identified the severity of illness, indwelling devices, and chronic wounds as independent predictors of co-colonization with VR E. faecalis and MRSA
Literature
1.
go back to reference Moellering RC Jr (1992) Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 14(6):1173–1176PubMedCrossRef Moellering RC Jr (1992) Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 14(6):1173–1176PubMedCrossRef
2.
go back to reference Palmer KL, Kos VN, Gilmore MS (2010) Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr Opin Microbiol 13(5):632–639PubMedCrossRef Palmer KL, Kos VN, Gilmore MS (2010) Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr Opin Microbiol 13(5):632–639PubMedCrossRef
3.
go back to reference Carmeli Y, Eliopoulos G, Mozaffari E, Samore M (2002) Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162(19):2223–2228PubMedCrossRef Carmeli Y, Eliopoulos G, Mozaffari E, Samore M (2002) Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162(19):2223–2228PubMedCrossRef
4.
go back to reference Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN (2007) Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 58(2):163–170PubMedCrossRef Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN (2007) Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 58(2):163–170PubMedCrossRef
5.
go back to reference Hayakawa K, Marchaim D, Vidaillac C, Lephart P, Pogue JM, Sunkara B, Kotra H, Hasan A, Shango M, Yerramalla Y, Osunlana AM, Chopra T, Dhar S, Salimnia H, Rybak MJ, Kaye KS (2011) Growing prevalence of vancomycin-resistant Enterococcus faecalis in the Region with the highest prevalence of vancomycin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 32(9):922–924PubMedCrossRef Hayakawa K, Marchaim D, Vidaillac C, Lephart P, Pogue JM, Sunkara B, Kotra H, Hasan A, Shango M, Yerramalla Y, Osunlana AM, Chopra T, Dhar S, Salimnia H, Rybak MJ, Kaye KS (2011) Growing prevalence of vancomycin-resistant Enterococcus faecalis in the Region with the highest prevalence of vancomycin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 32(9):922–924PubMedCrossRef
6.
go back to reference Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29(11):996–1011PubMedCrossRef Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29(11):996–1011PubMedCrossRef
8.
go back to reference Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46(5):668–674PubMedCrossRef Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46(5):668–674PubMedCrossRef
9.
go back to reference Perichon B, Courvalin P (2009) VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53(11):4580–4587PubMedCrossRef Perichon B, Courvalin P (2009) VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53(11):4580–4587PubMedCrossRef
10.
go back to reference Zhu W, Murray PR, Huskins WC, Jernigan JA, McDonald LC, Clark NC, Anderson KF, McDougal LK, Hageman JC, Olsen-Rasmussen M, Frace M, Alangaden GJ, Chenoweth C, Zervos MJ, Robinson-Dunn B, Schreckenberger PC, Reller LB, Rudrik JT, Patel JB (2010) Dissemination of an Enterococcus Inc18-Like vanA Plasmid, Associated with Vancomycin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother 54(10):4314–4320PubMedCrossRef Zhu W, Murray PR, Huskins WC, Jernigan JA, McDonald LC, Clark NC, Anderson KF, McDougal LK, Hageman JC, Olsen-Rasmussen M, Frace M, Alangaden GJ, Chenoweth C, Zervos MJ, Robinson-Dunn B, Schreckenberger PC, Reller LB, Rudrik JT, Patel JB (2010) Dissemination of an Enterococcus Inc18-Like vanA Plasmid, Associated with Vancomycin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother 54(10):4314–4320PubMedCrossRef
11.
go back to reference Reyes K, Malik R, Moore C, Donabedian S, Perri M, Johnson L, Zervos M (2010) Evaluation of risk factors for coinfection or cocolonization with vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus. J Clin Microbiol 48(2):628–630PubMedCrossRef Reyes K, Malik R, Moore C, Donabedian S, Perri M, Johnson L, Zervos M (2010) Evaluation of risk factors for coinfection or cocolonization with vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus. J Clin Microbiol 48(2):628–630PubMedCrossRef
12.
go back to reference Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Morris JG Jr, Strauss SM, Roghman MC, Nemoy LL, Standiford HC, Hebden JN, Harris AD (2005) Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg Infect Dis 11(10):1539–1544PubMedCrossRef Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Morris JG Jr, Strauss SM, Roghman MC, Nemoy LL, Standiford HC, Hebden JN, Harris AD (2005) Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg Infect Dis 11(10):1539–1544PubMedCrossRef
13.
go back to reference Sigurdardottir B, Berg JV, Hu J, Alamu J, McNutt LA, Diekema DJ, Herwaldt LA (2006) Descriptive epidemiology and case–control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 27(9):913–919PubMedCrossRef Sigurdardottir B, Berg JV, Hu J, Alamu J, McNutt LA, Diekema DJ, Herwaldt LA (2006) Descriptive epidemiology and case–control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 27(9):913–919PubMedCrossRef
14.
go back to reference Warren DK, Nitin A, Hill C, Fraser VJ, Kollef MH (2004) Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 25(2):99–104PubMedCrossRef Warren DK, Nitin A, Hill C, Fraser VJ, Kollef MH (2004) Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 25(2):99–104PubMedCrossRef
15.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef
16.
go back to reference Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. JAMA 185:914–919PubMedCrossRef Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. JAMA 185:914–919PubMedCrossRef
17.
go back to reference The Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Approved standard M100-S19. CLSI, Wayne The Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Approved standard M100-S19. CLSI, Wayne
18.
go back to reference Han SH, Chin BS, Lee HS, Jeong SJ, Choi HK, Kim CK, Kim CO, Yong D, Choi JY, Song YG, Lee K, Kim JM (2009) Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients. Infect Control Hosp Epidemiol 30(2):130–138PubMedCrossRef Han SH, Chin BS, Lee HS, Jeong SJ, Choi HK, Kim CK, Kim CO, Yong D, Choi JY, Song YG, Lee K, Kim JM (2009) Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients. Infect Control Hosp Epidemiol 30(2):130–138PubMedCrossRef
19.
go back to reference Franchi D, Climo MW, Wong AH, Edmond MB, Wenzel RP (1999) Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci. Clin Infect Dis 29(6):1566–1568PubMedCrossRef Franchi D, Climo MW, Wong AH, Edmond MB, Wenzel RP (1999) Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci. Clin Infect Dis 29(6):1566–1568PubMedCrossRef
20.
go back to reference Flannery EL, Wang L, Zollner S, Foxman B, Mobley HL, Mody L (2011) Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan. Clin Infect Dis 53(12):1215–1222PubMedCrossRef Flannery EL, Wang L, Zollner S, Foxman B, Mobley HL, Mody L (2011) Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan. Clin Infect Dis 53(12):1215–1222PubMedCrossRef
21.
go back to reference Bion JF, Edlin SA, Ramsay G, McCabe S, Ledingham IM (1985) Validation of a prognostic score in critically ill patients undergoing transport. Br Med J (Clin Res Ed) 291(6493):432–434CrossRef Bion JF, Edlin SA, Ramsay G, McCabe S, Ledingham IM (1985) Validation of a prognostic score in critically ill patients undergoing transport. Br Med J (Clin Res Ed) 291(6493):432–434CrossRef
Metadata
Title
Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation
Authors
K. Hayakawa
D. Marchaim
P. Bathina
E. T. Martin
J. M. Pogue
B. Sunkara
S. Kamatam
K. Ho
L. B. Willis
M. Ajamoughli
D. Patel
A. Khan
K. P. Lee
U. Suhrawardy
K. K. Jagadeesh
S. M. L. Reddy
M. Levine
F. Ahmed
A. M. Omotola
M. Mustapha
J. A. Moshos
M. J. Rybak
K. S. Kaye
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-013-1814-z

Other articles of this Issue 6/2013

European Journal of Clinical Microbiology & Infectious Diseases 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine